News

20-Oct-2025 by Jess Spiring As usage of weight loss medications surges and new therapies emerge, food businesses face a once-in-a-generation opportunity – or risk being left behind GLP-1 medications are no longer...

The rise of GLP-1 receptor agonists has triggered one of the most rapid and consequential shifts in the modern health and nutrition landscape. What began as a treatment for type...

10 Oct 2025 | By Jolanda van Hal GLP-1 receptor agonist medications are transforming the food and health landscape with their ability to combat the obesity epidemic and change people’s relationship with...

October 10, 2025 | Elaine Watson While GLP-1 receptor agonist drugs have not yet had seismic effects on the food industry, the second wave, which should be better tolerated and easier to...

Metabolic hormones such as glucagon-like peptide-1 (GLP-1s), glucose-dependent insulinotropic polypeptide (GIPs) and others are transforming the way we treat obesity, type 2 diabetes, related metabolic dysfunctions and more. Originally developed...

Two projects at the University of California, Davis, are among five announced by the U.S. National Science Foundation (NSF) that aim to accelerate the translation of AI-based approaches to protein...

Today, we’re proud to announce a partnership with UC Davis, one of the world’s leading research universities at the intersection of nutrition, health, and innovation, and widely recognized for advancing...

The Innovation Institute for Food & Health (IIFH) at the University of California (UC) Davis, US, has partnered with AG1 to accelerate new product development in nutrition and metabolic health....

UC Davis Innovation Institute for Food and Health and AG1 announce collaboration to advance precision nutrition to improve metabolic health By Marissa Pickard The University of California, Davis Innovation Institute...

PTFI was featured in The Analytical Chemist’s Special Edition on “Mass Spectrometry in 2025: Trends, Challenges, and Change”. Specifically, PTFI is highlighted in a write-up by Susan Richardson, former ASMS...

Abstract Monosaccharides exist in either “D” or “L” conformations, with L-sugars being much less abundant in nature and therefore classified as “rare sugars.” Rare sugars hold significant potential due to...

Abstract Rare sugars are valuable for food and pharmaceutical applications. D-Mannose, a low-calorie sweetener, is traditionally produced via chemical extraction from plant biomass, which is unsustainable, while enzymatic methods suffer...